fda bpc-157 compounding category 2 bulk drug substances list Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks for use in compounding for This just in: The FDA

This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change The experts will take votes on whether the FDA should allow seven popular peptides to be added to a list of substances that are safe for compounding by pharmacies. FDA Peptide Reclassification 2026: What It Means for Providers Industry Update: Interim 503A and 503B Bulks Lists New Revisions FDA's Overreach on Compounded Peptides Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding.

SKU: 54057106886 · From condeoeiras.edu.pt